Alpha-GPC
Italian multicenter trials (De Jesus Moreno, 2003) in Alzheimer's patients found Alpha-GPC improved memory scores more than placebo over 90 days. Sports studies (Bellar et al., 2015) confirm power output increases in athletes at 600mg. Of all choline sources, Alpha-GPC has the strongest acute cognitive data.
Mechanism of action
Alpha-GPC (alpha-glycerylphosphorylcholine) is the most bioavailable choline precursor. It delivers choline directly across the blood-brain barrier, where it is used to synthesise acetylcholine. It also stimulates growth hormone secretion and supports cell membrane phospholipid synthesis.
Clinical evidence summary
Italian multicenter trials (De Jesus Moreno, 2003) in Alzheimer's patients found Alpha-GPC improved memory scores more than placebo over 90 days. Sports studies (Bellar et al., 2015) confirm power output increases in athletes at 600mg. Of all choline sources, Alpha-GPC has the strongest acute cognitive data.
Human effect matrix
Based on human clinical trials only. Animal and in-vitro data excluded.
| Effect | Evidence | Magnitude | Studies |
|---|---|---|---|
| Acetylcholine Synthesis | strong | Large | 9 |
| Memory Encoding | strong | Moderate | 7 |
| Athletic Power Output | moderate | Moderate | 3 |
| Neuroprotection | moderate | Moderate | 4 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Documented benefits
- Acetylcholine synthesis
- Memory encoding
- Athletic power output
- Neuroprotection
Side effects & cautions
- Well tolerated
- Headache if combined with other cholinergics
- Potential cardiovascular concern at very high doses (>1200mg/day)
How to take
Stacking recommendations
Ingredients that pair well with Alpha-GPC and why.
Alpha-GPC provides immediate acetylcholine support; Lion's Mane drives long-term NGF synthesis. Neither overlaps mechanistically — a clean acute + long-term pairing.
Alpha-GPC handles acute memory encoding via acetylcholine; Bacopa handles memory consolidation and storage. Together they cover both encoding and consolidation stages of memory formation.
Huperzine A prevents acetylcholine breakdown while Alpha-GPC increases acetylcholine synthesis. Powerful combination in theory — but use with caution and low doses, as cholinergic overload (nausea, headache, muscle cramps) is a real risk. Not recommended without experience.
Frequently asked questions
Alpha-GPC vs Citicoline — which is better for focus?
Both are excellent. Alpha-GPC has a slight edge for acute cholinergic effects and is preferred for workout performance. Citicoline also provides cytidine (uridine precursor), giving it a broader neuroprotective profile. For pure focus and acetylcholine, Alpha-GPC wins slightly; for comprehensive brain health support, Citicoline is more complete. Don't stack them together — you'll get too much choline activity.
Is it safe to combine Alpha-GPC with Huperzine A?
Use caution. Both increase acetylcholine (Alpha-GPC via synthesis, Huperzine A via inhibiting breakdown). The combination is potent and can cause cholinergic overstimulation — symptoms include nausea, headache, excessive salivation, and muscle cramps. If combining, use lower doses of each (e.g. 200mg Alpha-GPC + 50mcg Huperzine A) and do not take daily.
Why does Alpha-GPC powder go sticky?
Alpha-GPC is highly hygroscopic — it absorbs water from the air quickly. This is normal and doesn't affect potency. Store in an airtight container in a cool, dry place. Capsule form avoids this problem entirely.
Is there a cardiovascular risk with Alpha-GPC?
A 2021 observational study suggested a possible association between high Alpha-GPC intake (>1200mg/day) and cardiovascular events via TMAO production. This was in older adults at very high doses. At standard supplementation doses (300–600mg/day) in healthy individuals, no cardiovascular signal has been found in controlled trials. The benefit/risk profile at standard doses is positive.
Top stacks containing Alpha-GPC
Alpha-GPC in Australia
Alpha-GPC (choline alfoscerate) does not appear under any of its names in the current TGA Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 -- the instrument that lists the ingredients allowed in listed and assessed listed medicines. The TGA states that 'if an ingredient isn't listed in the Determination, it can't be used in listed or assessed listed medicines.' An alpha-GPC product sold to an Australian buyer is therefore not an AUST L listed medicine, whatever route it reaches them by.
Why alpha-GPC can't carry an AUST L number
This site searched the full text of the current Determination (No. 2 2026, all six volumes as published on the Federal Register of Legislation) for 'alpha-GPC', 'choline alfoscerate', 'glycerophosphorylcholine' and 'glycerophosphocholine' and found no entry; the choline forms that are listed are choline bitartrate and choline dihydrogen citrate. Per the TGA's guidance, an ingredient absent from the Determination 'can't be used in listed or assessed listed medicines,' so a sponsor cannot obtain an AUST L number for a product whose active ingredient is alpha-GPC. Reviewed AU products on this site naming Alpha-GPC as a hero ingredient (Onnit Alpha Brain, Qualia Mind) carry no AUST L number in this site's Australian catalogue, consistent with that gap.
Products in Australia
- Qualia Mind8.1/10Personal Importation SchemeLocal price: $215/month
- NooCube7.8/10Personal Importation SchemeLocal price: $91/month
- Alpha Brain7.2/10Personal Importation SchemeLocal price: $122/month
TGA (AUST L)
Is alpha-GPC a TGA-listed medicine ingredient in Australia?
No. Alpha-GPC does not appear in the current Permissible Ingredients Determination under any of its names, and the TGA states an ingredient not in the Determination 'can't be used in listed or assessed listed medicines.' A product containing it is not an AUST L listed medicine.
What does the Personal Importation Scheme say about products that are not listed medicines?
The TGA's scheme 'allows individuals to import therapeutic goods not entered in the Australian Register of Therapeutic Goods (ARTG), provided certain conditions are met,' and the TGA adds that such imports 'are not evaluated by us, meaning their safety, quality and efficacy cannot be guaranteed.'
State & territory guides
Sources: TGA -- Permissible ingredients determination (overview) · Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 -- Schedule 1 heading · TGA -- Personal Importation Scheme · TGA -- Personal Importation Scheme
Regulatory note
Therapeutic goods available in Australia are regulated by the Therapeutic Goods Administration (TGA). AUST L–listed products carry pre-approved permitted indications; AUST R–registered products are higher-evidence. Imported products without TGA listing are not assessed by Australian regulators. This page is editorial, not promotional, and does not constitute medical advice. Always read the label and follow directions for use. Consult a qualified healthcare professional before starting any supplement.